Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers

Human rhinovirus (HRV) infections are usually self-limited but may be associated with serious consequences, particularly in those with asthma and chronic respiratory disease. Effective antiviral agents are needed for preventing and treating HRV illnesses. Ruprintrivir (Agouron Pharmaceuticals, Inc.,...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Hayden, Frederick G., Turner, Ronald B., Gwaltney, Jack M., Chi-Burris, Kathy, Gersten, Merril, Hsyu, Poe, Patick, Amy K., Smith, George J., Zalman, Leora S.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2003
Matèries:	Antiviral Agents
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296196/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14638501/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.12.3907-3916.2003
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!